As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...
Mark Cuban Cost Plus Drug Co. has seen exponential growth since its launch, supplying thousands of healthcare facilities with discounted generics in shortage.
Penn Medicine is partnering with billionaire investor Mark Cuban to streamline the availability of generic prescription drugs for its network of pharmacy locations. The nonprofit health system’s new ...
Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent ...
thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...
The Penn Medicine partnership with Mark Cuban's Cost Plus Drug Co. is designed to cut the health system's drug costs and improve access to prescription medicines. Penn Medicine has entered into a ...
International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...
Bipartisan bills in Congress would rein them in. And businesses such as Mark Cuban’s Cost Plus Drugs and smaller, “transparent PBMs” have tried to wean pharmaceutical companies and health plans from ...
Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...
To reduce medication costs and mitigate drug shortages, Penn Medicine is uniting with Mark Cuban Cost Plus Drug Co., the health system said Dec. 6. The Philadelphia-based organization will buy the ...
UNITED STATES, — The start of 2025 marks the start of the capping of prescription drug costs for Medicare Part D recipients.
thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are taking ...